← Evidence map

TrialDrug design, development and therapy2018

Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.

Jesse Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2018
2019
2020
2021
2022
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29950814